SCHEMBL8107843

SCHEMBL8107843

CN(C[C@@H](CC(=O)O)c1ccc(Cl)c(Cl)c1)C(=O)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 18/20 0.65
TACR1 P25103 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4873822 0.86 TACR2 (0.70) TACR2TACR1
SCHEMBL4610521 0.86 TACR2 (0.70) TACR2TACR1
SCHEMBL8870644 0.86 TACR2 (0.70) TACR2TACR1
SCHEMBL14263854 0.86 TACR2 (0.70) TACR2TACR1
SCHEMBL4610805 0.85 TACR2 (0.62) TACR2TACR1
SCHEMBL6774605 0.85 TACR2 (0.69) TACR2TACR1
SCHEMBL8870093 0.85 TACR2 (0.62) TACR2TACR1
SCHEMBL4876954 0.85 TACR2 (0.62) TACR2TACR1
SCHEMBL7313105 0.84 TACR2 (0.67) TACR2TACR1
SCHEMBL9110425 0.84 TACR2 (0.61) TACR2TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013644-A AIDS THERAPY MERCK & CO., INC. (US) 2000-01-11 US disclosed
US-5869496-A TREATING ASTHMA, EMESIS MERCK & CO., INC. (US) 1999-02-09 US disclosed
EP-0681571-B1 SPIRO-SUBSTITUTED AZACYCLES AS TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-07-29 EP disclosed
WO-1998025604-A1 SPIRO-SUBSTITUTED AZACYCLES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 1998-06-18 WO disclosed
EP-0681571-A1 SPIRO-SUBSTITUTED AZACYCLES AS TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO. INC. (US) 1995-11-15 EP disclosed
WO-1994017045-A1 SPIRO-SUBSTITUTED AZACYCLES AS TACHYKININ RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1994-08-04 WO disclosed